Skip to main content
. 2023 Jan 9;31(2):100. doi: 10.1007/s00520-022-07564-8

Fig. 3.

Fig. 3

Direction of the effects reported by each study for each outcome. OBS observational study; Q-Exp quasi-experimental study; RCT randomised clinical trial; SR systematic review; OS overall survival; PFS progression-free survival; m months; FS functional status; QoL quality of life; QoD quality of death; FI favours intervention (Systemic Oncological Treatment); ND no differences; FC favours comparison (Best Supportive Care/placebo/not specified); NR not reported. TGISG  The Gastrointestinal Study Group